The Cincinnati facility disruption is a known operational headwind with a clear timeline (full recovery by Q2 2027). Monitor the Q3 full earnings call for details on insurance recoveries and any further guidance revisions; the strong cash flow outlook partially offsets the revenue/EPS miss.
Price Chart
Executive Summary
Integra LifeSciences pre-announced preliminary Q3 2026 revenue of $410M-$412M and adjusted EPS of $0.55-$0.59, below consensus estimates of $422.4M and $0.64, driven by a ~$7M revenue hit from July flooding at its Cincinnati facility. Full-year 2026 guidance was lowered: revenue from $1.654B-$1.695B to $1.634B-$1.654B and adjusted EPS from $2.40-$2.50 to $2.30-$2.40, though the company expects strong operating cash flow of $190M-$200M and insurance recoveries to mitigate a substantial portion of the earnings impact.
Key Financial Metrics
Key Facts
- Preliminary Q3 2026 revenue expected between $410M and $412M, below consensus of $422.4M
- Preliminary Q3 2026 adjusted EPS expected between $0.55 and $0.59, below consensus of $0.64
- Flooding at Cincinnati facility negatively impacted Q3 revenue by ~$7M and is expected to impact Q4 revenue by ~$15M-$20M
- Full-year 2026 revenue guidance lowered from $1.654B-$1.695B to $1.634B-$1.654B
- Full-year 2026 adjusted EPS guidance lowered from $2.40-$2.50 to $2.30-$2.40
- Full manufacturing operations at Cincinnati facility expected to resume in Q2 2027
- Company expects Q3 operating cash flow >$85M and full-year operating cash flow of ~$190M-$200M
- Insurance recoveries expected to mitigate substantial portion of earnings impact from disruption
Financial Impact
Q3 revenue miss of ~$10M-$12M vs consensus; full-year revenue guidance cut by $20M-$41M; full-year adjusted EPS guidance cut by $0.10
Risk Factors
- Cincinnati facility recovery may take longer or cost more than currently estimated
- Insurance recoveries may be less than expected or delayed
- Broader business assumptions for H2 2026 may prove optimistic if supply disruptions persist
- Potential asset impairments or additional costs from the flooding event
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000917520-26-000067 |
| Exhibit: ex991_q3pressreleasepreann.htm | 0000917520-26-000067 |
| Document: 0000917520-26-000067-index-headers.html | 0000917520-26-000067 |
| Document: 0000917520-26-000067-index.html | 0000917520-26-000067 |
| Document: 0000917520-26-000067.txt | 0000917520-26-000067 |
| 8-K Data (Synthetic) | 0000917520-26-000067 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | 8-K | $11.84 | awaiting T+5 | — | $12.13 (−2.41%) |
Oct 19, 2026 6d ago | 8-K | $13.33 | awaiting T+5 | — | $12.13 (−9.04%) |
Oct 14, 2026 12d ago | Court Ruling | $13.53 $12.33 | ▼ −8.91% | ▼ −7.89% | $12.13 (−10.38%) |
Oct 13, 2026 12d ago | 3 | $13.18 $11.84 | ▼ −10.13% | ▼ −10.59% | $12.13 (−7.97%) |
Oct 9, 2026 16d ago | 8-K | $13.98 $13.45 | ▲ +3.79% | ▲ +2.30% | $12.13 (+13.27%) |
Oct 6, 2026 20d ago | Press Release | $13.32 | awaiting T+5 | — | $12.13 (−8.97%) |
Oct 2, 2026 24d ago | 8-K | $12.68 $13.44 | ▼ −5.99% | ▼ −4.83% | $12.13 (+4.38%) |
Oct 2, 2026 24d ago | Press Release | $12.68 $13.44 | ▼ −5.99% | ▼ −4.83% | $12.13 (+4.38%) |
Sep 8, 2026 6w ago | 8-K | $16.26 $15.71 | ▼ −3.38% | ▼ −2.72% | $12.13 (−25.43%) |
May 8, 2026 24w ago | 8-K | $13.97 $14.11 | ▲ +1.00% | ▲ +1.09% | $12.13 (−13.21%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers